Christopher O’Brien

3.9k citations
73 papers · 3.0k · 1 hit paper · h-index 26

Impact in

  • Hepatology top 1%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
  • Physiology top 2%
    • Asthma and respiratory diseases

Papers in

    • Hepatitis C virus research 18
    • Liver Disease and Transplantation 11
    • Hepatocellular Carcinoma Treatment and Prognosis 4
    • Liver Disease Diagnosis and Treatment 14
    • Hepatitis B Virus Studies 9

Christopher O’Brien

68 papers receiving 2.8k citations

Christopher O’Brien's Hit Papers

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials 2015 · 886 citations
8860+3+7Years since publication250500750

Peers

Christopher O’Brien
Comparison fields: 5 of 141
  • Hepatology 857
  • Physiology 770
  • Management Information Systems 272
  • Immunology and Allergy 149
  • Transplantation 61
Replace Claire O’Brien with:
Claire O’Brien United Kingdom
Dong‐Hoon Yang South Korea
TK Chan China
Zhu Wang United States
Josep Llach Spain
William Stevenson Australia
David Talbot United Kingdom
Moshe Leshno Israel
Zoltán Kaló Hungary
Chung‐Jen Chen Taiwan
Christopher O’Brien relative to Claire O’Brien United Kingdom Claire O’Brien's profile →
Citations per field
00.5×5×10.6×
Claire O’Brien · 1×
Citations per year

Countries citing papers authored by Christopher O’Brien

Since Specialization
Citations

This map shows the geographic impact of Christopher O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher O’Brien more than expected).

Fields of papers citing papers by Christopher O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher O’Brien. The network helps show where Christopher O’Brien may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher O’Brien Line = papers co-authored together Christopher O’Brien links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Hit paper breakdown →
2015886
2 2004191
3 2007176
4 1999155
5 2014137
6 1999100
7 200492
8 200188
9 200981
10 198675
11 201574
12
Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores.
199570
13 200463
14 201357
15 200448
16 201346
17 202145
18 200442
19 200642
20 200739

About Christopher O’Brien

Christopher O’Brien is a scholar working on Hepatology, Epidemiology, Strategy and Management, Surgery and Management Information Systems, having authored 73 papers that have together received 3.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (18 papers), Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (11 papers), Hepatitis B Virus Studies (9 papers), Asthma and respiratory diseases (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Insurance and Financial Risk Management (4 papers) and Quality and Supply Management (4 papers). The work is most often cited by research in Hepatology (857 citations), Physiology (770 citations), Management Information Systems (272 citations), Immunology and Allergy (149 citations) and Transplantation (61 citations). Christopher O’Brien has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include James Zangrilli, Stephanie Korn, Kevin Murphy, Jorge Máspero, Eric D. Bateman, Philip G. Bardin, Mario Castro, Guy Brusselle, Michael E. Wechsler and Dong Li. Their work appears in journals such as International Journal of Production Economics, Liver Transplantation, The American Journal of Gastroenterology, Digestive Diseases and Sciences and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact